Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maarten te Dorsthorst"'
Autor:
Krissie Lenting, Corina N. A. M. van den Heuvel, Anne van Ewijk, Duaa ElMelik, Remco de Boer, Elizabeth Tindall, Ge Wei, Benno Kusters, Maarten te Dorsthorst, Mark ter Laan, Martijn A. Huynen, William P. Leenders
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Many biology-based precision drugs are available that neutralize aberrant molecular pathways in cancer. Molecular heterogeneity and the lack of reliable companion diagnostic biomarkers for many drugs makes targeted treatment of cancer inaccu
Externí odkaz:
https://doaj.org/article/295b2e41b8a84f889a698d9f2d2d97e1
Autor:
Frederick J. A. Meijer, Monique M. Anten, Sjoert A. H. Pegge, Vivianne C. G. Tjan-Heijnen, Benno Küsters, Koos Hovinga, Maikel Verduin, Alida A. Postma, Maarten te Dorsthorst, Sander M. J. van Kuijk, Ernst-Jan M. Speel, Mark ter Laan, Elles G. M. Revenich, Ann Hoeben, Sergey Primakov, Wendy W.J. de Leng, Inge Compter, Olaf E. M. G. Schijns, Martijn P. G. Broen, Henry C. Woodruff, Onno P.M. Teernstra, Philippe Lambin, Bram Ramaekers, Jan Beckervordersandforth, Daniëlle B.P. Eekers, Linda Ackermans, Marc Vooijs
Publikováno v:
Cancers, 13
Cancers, 13, 4
Cancers
Volume 13
Issue 4
Cancers, 13(4):722. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 722, p 722 (2021)
Cancers, 13, 4
Cancers
Volume 13
Issue 4
Cancers, 13(4):722. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 722, p 722 (2021)
Glioblastoma (GBM) is the most malignant primary brain tumor for which no curative treatment options exist. Non-invasive qualitative (Visually Accessible Rembrandt Images (VASARI)) and quantitative (radiomics) imaging features to predict prognosis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1eee61148171a4bad3da7daa602314
http://hdl.handle.net/2066/231620
http://hdl.handle.net/2066/231620
Autor:
Linda A.A. Jacobi-Postma, Ernst-Jan M. Speel, Elles G. M. Revenich, Anton Meijer, Philippe Lambin, Sergey Primakov, Mark ter Laan, Sjoert A. H. Pegge, Marc Vooijs, Ann Hoeben, Inge Compter, Monique M. Anten, Martijn P. G. Broen, Olaf E. M. G. Schijns, Daniëlle B.P. Eekers, Jan Beckervordersandforth, Arthur Jochems, Wendy W.J. de Leng, Maikel Verduin, Maarten te Dorsthorst, Sander M. J. van Kuijk, Vivianne C. G. Tjan-Heijnen, Linda Ackermans
Publikováno v:
Neuro Oncol
INTRODUCTION Tumor heterogeneity poses one of the major limitations in improving the treatment for glioblastoma (GBM), which calls for new clinically relevant predictive models. This study aims to investigate non-invasive diagnostic methods, includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119c4c2189efb426e6155bcc566e1d41
https://europepmc.org/articles/PMC6847161/
https://europepmc.org/articles/PMC6847161/
Autor:
Mark ter Laan, Elizabeth Tindall, Maarten te Dorsthorst, Ge Wei, Martijn A. Huynen, Duaa Elmelik, Benno Küsters, Remco de Boer, William P.J. Leenders, Anne van Ewijk, Krissie Lenting, Corina N. A. M. van den Heuvel
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-15 (2019)
Acta Neuropathologica Communications, 7, 185
Acta Neuropathologica Communications, 7, 1, pp. 185
Acta Neuropathologica Communications
Acta Neuropathologica Communications, 7, 185
Acta Neuropathologica Communications, 7, 1, pp. 185
Acta Neuropathologica Communications
Contains fulltext : 214227.pdf (Publisher’s version ) (Open Access) Many biology-based precision drugs are available that neutralize aberrant molecular pathways in cancer. Molecular heterogeneity and the lack of reliable companion diagnostic biomar